High Denial Rates of Medicare Advantage Organizations Under Scrutiny
Explore concerns over high denial rates by Medicare Advantage organizations for vital services, addressing critical implications for patient care and access.
Explore concerns over high denial rates by Medicare Advantage organizations for vital services, addressing critical implications for patient care and access.
Learn about the proposed Medicare drug price negotiation rule and its implications on the pharmaceutical industry and state regulations.
Discover the latest OIG compliance guidance for Medicare Advantage programs and its implications for providers. Enhance your compliance infrastructure today!
Explore the financial challenges faced by Social Security and Medicare trust funds, projected insolvency dates, and potential benefit reductions for future beneficiaries.
CMS is evaluating OPO certification under new performance measures, impacting Medicare reimbursements and organ transplantation operations significantly.
Discover how seniors can protect themselves from Medicare fraud and costly scams. Learn about the types of fraud and how to report suspicious activity.
Dr. Oz discusses ACA enrollment validity and fraud risk, emphasizing new CMS regulations to enhance oversight and prevent improper enrollments.
Explore significant updates to the Independent Dispute Resolution process under the No Surprises Act, enhancing efficiency in healthcare payment disputes.
U.S. Supreme Court upholds the Medicare Drug Price Negotiation Program, impacting pharmaceutical firms and regulatory strategies in healthcare. Explore key updates.
Discover how AHCA's Better Way agenda enhances care for the elderly by streamlining regulations and improving compliance processes for skilled nursing facilities.